Remaining Resilient after 2020: Utilizing Cleanrooms on Demand to Accelerate Early-Phase Biopharmaceutical Manufacturing

Time: 3:00 pm
day: Day Two


  • Current industry challenges around the transition from R&D through early phase clinical manufacturing
  • Unique challenges with novel therapeutics such as Cell and Gene Therapy and Microbiome based therapies
  • Comparison of existing options to overcome such challenges versus Cleanrooms on Demand